OM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Outset Medical Inc (OM) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has potential upside in the next month, the company's financial performance is weak, with declining revenue, net income, and EPS. Additionally, there are no significant positive catalysts or trading signals to justify immediate action. A hold strategy is recommended until more favorable conditions emerge.
The MACD is positive but contracting, RSI is neutral at 71.023, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot point (4.446) with resistance at 4.736 and support at 4.155.
The company's gross margin increased by 16.15% YoY, and analysts maintain a Buy rating with optimism about a new product and a growing deal pipeline.
Revenue, net income, and EPS have significantly declined YoY. There is no recent news or significant trading activity from insiders, hedge funds, or Congress. Options data indicates bearish sentiment with a high put-call ratio.
In Q4 2025, revenue dropped by 2.01% YoY to $28.87M, net income fell by 23.98% YoY to -$19.49M, and EPS declined by 85.32% YoY to -1.07. However, gross margin improved to 42.36%, up 16.15% YoY.
Analysts have lowered price targets (BTIG to $15 from $17, TD Cowen to $12 from $15) but maintain a Buy rating. They highlight stability in the salesforce, a new product pipeline, and improving margins as positive factors.
